Altogether, these results suggest that the SOX9 activation network and the expansion of liver progenitor cells either by increased survival or the dedifferentiation of hepatocytes are common mechanisms of fibrosis progression in NASH and other chronic liver diseases leading to cirrhosis. The gene discussed is SOX9; the disease is metabolic dysfunction-associated steatohepatitis.